Human rhinovirus impairs the innate immune response to bacteria in alveolar macrophages in chronic obstructive pulmonary disease
File(s)Data supplement V6.docx (742.28 KB)
Supporting information
Author(s)
Type
Journal Article
Abstract
Rationale Human rhinovirus (HRV) is a common cause of COPD exacerbations. Secondary bacterial infection is associated with more severe symptoms and delayed recovery. Alveolar macrophages clear bacteria from the lung and maintain lung homeostasis through cytokine secretion. These processes are defective in COPD. The effect of HRV on macrophage function is unknown. Objectives To investigate the effect of HRV on phagocytosis and cytokine response to bacteria by alveolar macrophages and monocyte derived macrophages (MDM) in COPD and healthy controls. Methods Alveolar macrophages were obtained by bronchoscopy and MDM by adherence. Macrophages were exposed to HRV 16 (multiplicity of infection 5), polyI:C 30μg/ml, interferon (IFN)-β 10μg/ml, IFN-γ 10μg/ml or medium control for 24 hours. Phagocytosis of fluorescently-labelled Haemophilus influenzae or Streptococcus pneumoniae was assessed by fluorimetry. CXCL8, TNF and IL-10 release was measured by ELISA. Main Results HRV significantly impaired phagocytosis of H. influenzae by 23% in MDM (n=37) and 18% in alveolar macrophages (n=20) in COPD. HRV also significantly reduced phagocytosis of S. pneumoniae by 33% in COPD MDM. There was no effect in healthy controls. Phagocytosis of H. influenzae was impaired by polyI:C but not IFN-β or IFN-γ. HRV significantly reduced cytokine responses to H. influenzae. The IL-10 response to H. influenzae was significantly impaired by polyI:C, IFN-β and IFN-γ. Conclusions HRV impairs phagocytosis of bacteria in COPD which may lead to an outgrowth of bacteria. HRV also impairs cytokine responses to bacteria via the TLR3/IFN pathway which may prevent resolution of inflammation leading to prolonged exacerbations in COPD.
Date Issued
2019-06-15
Date Acceptance
2018-12-14
Citation
American Journal of Respiratory and Critical Care Medicine, 2019, 199 (12), pp.1496-1507
ISSN
1073-449X
Publisher
American Thoracic Society
Start Page
1496
End Page
1507
Journal / Book Title
American Journal of Respiratory and Critical Care Medicine
Volume
199
Issue
12
Copyright Statement
© 2018 by the American Thoracic Society
Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Janssen Research & Development Llc
Medical Research Council (MRC)
Asthma UK
Asthma UK
Biotechnology and Biological Sciences Research Council (BBSRC)
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30562053
Grant Number
RCF funding from LNW CRN
n/a
G1001372
CH11SJ
CH11SJ
BB/L015129/1
Subjects
Bacteria
COPD
Macrophages
Phagocytosis
Rhinovirus
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2018-12-18